TELA BIO INC. - COMMON STOCK

TELA Bio to Participate in Upcoming Needham & Co. 21st Annual Healthcare Virtual Conference

30 Mar 2022 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Reports Fourth Quarter and Full Year 2021 Financial Results

21 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL

16 Mar 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio to Announce Fourth Quarter and Full Year 2021 Financial Results

07 Mar 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution

03 Mar 2022 06:00:01 By Nasdaq GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

25 Feb 2022 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Reports Strong Third Quarter 2021 Revenues Reflecting Continued Growth Driven by Increased Demand

10 Nov 2021 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Announces Publication of 12-Month Results from the BRAVO Study with Continued Positive Outcomes Through 24 months

09 Nov 2021 06:00:03 By Nasdaq GlobeNewswire

TELA Bio to Participate in Three Upcoming Conferences

08 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio and Next Science Enter into Exclusive Distribution Agreement in the Plastic Reconstructive Market for Advanced Anti-Biofilm Surgical Wash

01 Nov 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio to Announce Third Quarter 2021 Financial Results

27 Oct 2021 15:01:00 By Nasdaq GlobeNewswire

TELA Bio Appoints Roberto Cuca as Chief Operating Officer and Chief Financial Officer

27 Sep 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio® Announces New Data on Use of OviTex in a Range of Hernia Repair Applications, Including Novel ReBAR (Reinforced Biologic Augmented Repair) Technique

13 Sep 2021 06:00:01 By Nasdaq GlobeNewswire

TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Presentations at SAGES 2021

16 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

TELA Bio Reports Record Second Quarter 2021 Revenues Driven by Increased Demand

11 Aug 2021 15:01:00 By Nasdaq GlobeNewswire

TELA Bio to Participate in Canaccord Genuity’s 41st Annual Growth Conference

03 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

TELA Bio to Announce Second Quarter 2021 Financial Results

28 Jul 2021 06:00:01 By Nasdaq GlobeNewswire

NHS Surgeon First in Europe to Implant TELA Bio's OviTex® LPR Reinforced Tissue Matrix

21 Jul 2021 07:28:48 By Nasdaq GlobeNewswire

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

14 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

TELA Bio Announces Changes to its Board of Directors

02 Jun 2021 06:00:01 By Nasdaq GlobeNewswire